Cytomegalovirus Infection Management in Allogeneic Stem Cell Transplant Recipients: a National Survey in Spain

Carlos Solano; Rafael de la Cámara; Lourdes Vázquez; Javier López; Estela Giménez; David Navarro

doi:10.1128/JCM.01057-15

Cytomegalovirus Infection Management in Allogeneic Stem Cell Transplant Recipients: a National Survey in Spain

J Clin Microbiol. 2015 Aug;53(8):2741-4. doi: 10.1128/JCM.01057-15. Epub 2015 Jun 10.

Authors

Carlos Solano¹, Rafael de la Cámara², Lourdes Vázquez³, Javier López⁴, Estela Giménez⁵, David Navarro⁶

Affiliations

¹ Hematology and Medical Oncology Service, Hospital Clínico Universitario, Fundación INCLIVA, Valencia, Spain.
² Hematology Service, Hospital de la Princesa, Madrid, Spain.
³ Hematology Service, Hospital General de Salamanca, Salamanca, Spain.
⁴ Hematology Service, Hospital Ramón y Cajal, Madrid, Spain.
⁵ Microbiology Service, Hospital Clínico Universitario, Fundación INCLIVA, Valencia, Spain.
⁶ Microbiology Service, Hospital Clínico Universitario, Fundación INCLIVA, Valencia, Spain Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain [email protected].

Abstract

This study gathered information about current practices of cytomegalovirus (CMV) infection management in allogeneic stem cell transplant recipients at Spanish centers. A wide variety of preemptive antiviral therapy strategies for CMV infection guided by real-time PCR assays was found, yet the incidence of CMV disease was low (<3%).

MeSH terms

Adult
Antiviral Agents / therapeutic use*
Case Management
Chemoprevention / methods*
Cytomegalovirus Infections / diagnosis*
Cytomegalovirus Infections / drug therapy
Cytomegalovirus Infections / prevention & control*
Humans
Molecular Diagnostic Techniques / methods*
Real-Time Polymerase Chain Reaction
Spain
Stem Cell Transplantation / adverse effects*
Transplantation, Homologous / adverse effects*

Substances

Antiviral Agents